Coherently, active DNA methylation changes during early tumor development shown by methylation array data, elevated DNA methylation pathway activity, and low IDH1 expression presented by proteomics data support hypermethylation in PTN, which could be further confirmed by the decrease of a-KG and increase of 2-HG in the metabolomic assay. Here, IDH1 is linked to neoplasm.